Nomad Foods Limited (NOMD)
(Delayed Data from NYSE)
$17.45 USD
-0.05 (-0.29%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $17.47 +0.02 (0.11%) 7:58 PM ET
4-Sell of 5 4
A Value C Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$17.45 USD
-0.05 (-0.29%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $17.47 +0.02 (0.11%) 7:58 PM ET
4-Sell of 5 4
A Value C Growth D Momentum B VGM
Zacks News
Helen of Troy (HELE) Q3 Earnings Top Estimates, Sales Decline
by Zacks Equity Research
Helen of Troy's (HELE) third-quarter results reflect gains from Project Pegasus, though Organic sales remain under pressure due to reduced consumer demand in some categories.
Clorox (CLX) Navigates Challenges, Poised for Sustained Growth
by Zacks Equity Research
Clorox's (CLX) focus on maintaining competitive pricing, sustained innovation, and adherence to a balanced spending approach bodes well amid input-cost inflation and supply-chain woes.
Hain Celestial (HAIN) Poised on Reimagined Strategy, E-Commerce
by Zacks Equity Research
Hain Celestial's (HAIN) strategic focus on brand building, channel expansion and innovation positions it for robust growth.
Service Corporation (SCI) Rallies More Than 20% in 3 Months
by Zacks Equity Research
Service Corporation (SCI) benefits from its expansion initiatives. Relatively stable demand for deathcare products has been working well.
Product Launches Aid Nu Skin (NUS), Macroeconomic Hurdles Ail
by Zacks Equity Research
Nu Skin (NUS) is benefiting from the Nu Vision 2025 strategy driven by a dynamic affiliate opportunity platform. However, escalating macroeconomic pressures are hampering key markets.
Campbell Soup (CPB) Poised on Snacks Unit, Strategic Execution
by Zacks Equity Research
Campbell Soup (CPB) benefits from its robust Snacks business. Strong execution of its strategic plan also positions the company well amid cost inflation and a volatile consumer landscape.
Should Value Investors Buy Nomad Foods Limited (NOMD) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy Nomad Foods Limited (NOMD) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Wall Street Analysts See a 38.8% Upside in Nomad Foods (NOMD): Can the Stock Really Move This High?
by Zacks Equity Research
The mean of analysts' price targets for Nomad Foods (NOMD) points to a 38.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Are Investors Undervaluing Nomad Foods Limited (NOMD) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should Value Investors Buy Kraft Heinz Company (KHC) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Wall Street Analysts Think Nomad Foods (NOMD) Could Surge 34.97%: Read This Before Placing a Bet
by Zacks Equity Research
The consensus price target hints at a 35% upside potential for Nomad Foods (NOMD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Implied Volatility Surging for Nomad Foods (NOMD) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Nomad Foods (NOMD) stock based on the movements in the options market lately.
Do Options Traders Know Something About Nomad Foods (NOMD) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Nomad Foods (NOMD) stock based on the movements in the options market lately.
Nomad Foods (NOMD) Reaffirms Q3 & Full-Year 2023 Guidance
by Zacks Equity Research
Nomad Foods (NOMD) continues to expect revenues in the range of EUR750-EUR755 million for the third quarter of 2023.
Nomad Foods (NOMD) Tops Q2 Earnings Estimates
by Zacks Equity Research
Nomad Foods (NOMD) delivered earnings and revenue surprises of 4.76% and 0.55%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Aramark (ARMK) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Aramark (ARMK) delivered earnings and revenue surprises of 9.09% and 3.96%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Post Holdings (POST) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Post Holdings (POST) delivered earnings and revenue surprises of 70.79% and 2.21%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Clorox (CLX) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Clorox (CLX) delivered earnings and revenue surprises of 40.34% and 7.25%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Molson Coors (TAP) Rallies 25.1% in 1H23: Things to Note
by Zacks Equity Research
Molson Coors (TAP) remains well placed on the back of brand strength, product innovation and a revitalization plan.
Guess? (GES) Exhibits Bright Prospects, Headwinds Persist
by Zacks Equity Research
Guess? (GES) has been gaining from its business strength, strategic business plan and strong omnichannel capabilities. However, weakness in America's retail business remains a concern.
Coty (COTY) Focuses on Boosting Global Presence, Ups FY23 View
by Zacks Equity Research
Coty (COTY) is hosting its first investor event in Paris, wherein it is set to provide details regarding the financial performance, operating landscape and growth agenda. It is also raising guidance.
Costco (COST) Witnesses a Drop in Comparable Sales in June
by Zacks Equity Research
Costco's (COST) June sales results disappoint investors. Comparable sales decline 1.4% during the month under review.
Here's Why Hershey (HSY) is Marching Ahead of Its Industry
by Zacks Equity Research
Hershey's (HSY) shares outperform the industry, benefiting from improved net price realization and high consumer demand.
Sprouts Farmers (SFM) Thrives on Product Innovation, Expansion
by Zacks Equity Research
Sprouts Farmers (SFM) has been redefining strategies and upgrading capabilities to stay ahead of the curve.